生殖遺傳學市場：按技術分類

預計到 2026 年，生殖遺傳學市場規模將達到 82.4 億美元，到 2033 年將達到 190.2 億美元。預計從 2026 年到 2033 年，該市場將以 12.7% 的複合年成長率成長。

全球生殖遺傳學市場是醫療保健產業內一個快速發展的領域，涵蓋了旨在評估生殖健康、懷孕和分娩結果的先進基因檢測和篩檢技術。

這個專業市場專注於基因分析服務和產品，旨在幫助醫療保健專業人員、生育診所和患者就生育計劃、妊娠管理和遺傳風險評估做出明智的決定。生殖遺傳學整合了尖端的分子診斷、基因測序技術和生物資訊學平台，用於識別可能影響生育成功率和後代健康的染色體異常、遺傳疾病和遺傳性疾病。

該市場涵蓋多種調查方法，例如胚胎著床前遺傳學檢測 (PGT)、非侵入性產前檢測 (NIPT)、帶因者篩檢和遺傳諮詢服務。隨著個人化和預防性醫療在全球醫療保健系統中日益重要，生殖遺傳學正逐漸成為現代生育治療和產前護理方案中不可或缺的一部分。

市場動態

全球生殖遺傳學市場主要受以下幾個強勁因素驅動，這些因素持續推動已開發國家和新興國家醫療保健市場的擴張。遺傳疾病和染色體異常的日益普遍，以及全球高齡生產數量的成長趨勢，顯著提升了對全面基因篩檢服務的需求。

由於高齡生產，尤其是35歲以後懷孕，會增加遺傳併發症的風險，醫療保健機構越來越建議定期進行基因檢測。次世代定序（NGS）、微陣列分析和人工智慧診斷平台等技術的進步顯著提高了檢測的準確性，同時降低了成本和縮短了反應時間，使更多患者能夠獲得這些服務。

隨著醫療專業人員和患者對早期基因檢測益處的認知不斷提高，生育診所和醫療機構對這項技術的採用率也隨之提高。然而，市場仍存在諸多限制因素。先進的基因檢測程序高成本，對於發展中地區的患者以及缺乏全面醫療保險的患者而言，這可能是一項難以負擔的障礙。

各國監管法規的複雜性和核准流程的差異可能會阻礙新技術進入市場，並延遲產品上市。此外，圍繞基因檢測的倫理問題，例如基因歧視和基因資訊隱私等，也可能導致某些患者群體猶豫不決。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球生殖遺傳學市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球生殖遺傳市場報告的目標受眾是業內各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球生殖遺傳學市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球生殖遺傳學市場：依技術分類，2021-2033年

• 胚胎著床前遺傳學檢測（PGT）
• 職業篩檢
• 產前基因檢測
• 新生兒基因檢測

第5章 全球生殖遺傳學市場：依應用領域分類，2021-2033年

• 不孕症和體外受精（IVF）項目
• 遺傳疾病風險評估
• 染色體異常檢測
• 胎兒健康篩檢
• 遺傳疾病的診斷
• 復發性流產的調查

第6章 全球生殖遺傳市場：依產品類型分類，2021-2033年

• 設備和系統
• 耗材和試劑
• 軟體和服務

第7章 全球生殖遺傳學市場：依樣本類型分類，2021-2033年

• 胚胎
• 羊水
• 母體血
• 口腔黏膜拭子
• 臍帶血

第8章 全球生殖遺傳市場：依最終使用者分類，2021-2033年

• 不孕症治療診所和體外受精（IVF）中心
• 醫院/診斷檢查室
• 研究和學術機構
• 遺傳諮詢中心

第9章 全球生殖遺傳學市場：依方法論分類，2021-2033年

• 次世代定序（NGS）
• 聚合酵素鏈鎖反應（PCR）
• 螢光原位雜合反應（FISH）
• 比較基因雜合反應（CGH）
• 微陣列分析

第10章 全球生殖遺傳學市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第11章 競爭格局

• Illumina
• Thermo Fisher Scientific
• Roche Diagnostics
• QIAGEN
• Agilent Technologies
• Revvity（PerkinElmer）
• Bio-Rad Laboratories
• Pacific Biosciences
• Oxford Nanopore Technologies
• MGI Tech
• CooperSurgical
• Hamilton Thorne
• Vitrolife
• Takara Bio
• Promega Corporation

第12章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第13章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Reproductive Genetics Market is estimated to be valued at USD 8.24 Bn in 2026 and is expected to reach USD 19.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2033.

The global reproductive genetics market represents a rapidly evolving segment within the broader healthcare industry, encompassing advanced genetic testing and screening technologies designed to assess reproductive health and fertility outcomes.

This specialized market focuses on genetic analysis services and products that help healthcare providers, fertility clinics, and patients make informed decisions regarding reproductive planning, pregnancy management, and genetic risk assessment. Reproductive genetics integrates cutting-edge molecular diagnostics, genomic sequencing technologies, and bioinformatics platforms to identify chromosomal abnormalities, genetic disorders, and hereditary conditions that may impact reproductive success or offspring health.

The market encompasses various testing methodologies including preimplantation genetic testing (PGT), non-invasive prenatal testing (NIPT), carrier screening, and genetic counseling services. As healthcare systems worldwide increasingly prioritize personalized medicine and preventive care, reproductive genetics has emerged as a critical component in modern fertility treatments and prenatal care protocols.

Market Dynamics

The global reproductive genetics market is primarily driven by several compelling factors that continue to fuel its expansion across developed and emerging healthcare markets. The increasing prevalence of genetic disorders and chromosomal abnormalities, combined with rising maternal age trends globally, has significantly heightened the demand for comprehensive genetic screening services.

Advanced maternal age, particularly pregnancies after 35 years, carries elevated risks of genetic complications, driving healthcare providers to recommend routine genetic testing protocols. Technological breakthroughs in next-generation sequencing (NGS), microarray analysis, and artificial intelligence-powered diagnostic platforms have substantially improved testing accuracy while reducing costs and turnaround times, making these services more accessible to broader patient populations.

Growing awareness among healthcare professionals and patients regarding the benefits of early genetic detection has fostered increased adoption rates across fertility clinics and healthcare institutions. However, the market faces notable restraints including high costs associated with advanced genetic testing procedures, which may limit accessibility for patients in developing regions or those without comprehensive insurance coverage.

Regulatory complexities and varying approval processes across different countries can impede market entry for new technologies and delay product launches. Additionally, ethical concerns surrounding genetic testing, including issues related to genetic discrimination and privacy of genetic information, may create hesitancy among certain patient demographics.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global reproductive genetics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies, Revvity (PerkinElmer), Bio-Rad Laboratories, Pacific Biosciences, Oxford Nanopore Technologies, MGI Tech, CooperSurgical, Hamilton Thorne, Vitrolife, Takara Bio, and Promega Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global reproductive genetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reproductive genetics market

Market Segmentation

• Technology Insights (Revenue, USD Bn, 2021 - 2033)
• Preimplantation Genetic Testing (PGT)
  • PGT-A (Aneuploidy)
  • PGT-M (Monogenic Disorders)
  • PGT-SR (Structural Rearrangements)
• Carrier Screening
  • Targeted Mutation Panels
  • Expanded Carrier Screening
• Prenatal Genetic Testing
  • Non-Invasive Prenatal Testing (NIPT)
  • Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
• Newborn Genetic Testing
  • Whole Exome Sequencing
  • Targeted Gene Panels
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Infertility and IVF Programs
• Genetic Disease Risk Assessment
• Chromosomal Abnormality Detection
• Fetal Health Screening
• Inherited Disorder Diagnosis
• Recurrent Pregnancy Loss Investigation
• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Instruments and Systems
  • Sequencers
  • PCR Systems
  • Microarray Platforms
• Consumables and Reagents
  • DNA Extraction Kits
  • Amplification Reagents
  • Hybridization Probes
• Software and Services
  • Genetic Data Analysis Tools
  • Counseling and Interpretation Services
• Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
• Embryo
• Amniotic Fluid
• Maternal Blood
• Buccal Swab
• Cord Blood
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Fertility Clinics and IVF Centers
• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Genetic Counseling Centers
• Methodology Insights (Revenue, USD Bn, 2021 - 2033)
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescence In Situ Hybridization (FISH)
• Comparative Genomic Hybridization (CGH)
• Microarray Analysis
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Illumina
• Thermo Fisher Scientific
• Roche Diagnostics
• QIAGEN
• Agilent Technologies
• Revvity (PerkinElmer)
• Bio-Rad Laboratories
• Pacific Biosciences
• Oxford Nanopore Technologies
• MGI Tech
• CooperSurgical
• Hamilton Thorne
• Vitrolife
• Takara Bio
• Promega Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Reproductive Genetics Market, By Technology
  • Global Reproductive Genetics Market, By Application
  • Global Reproductive Genetics Market, By Product Type
  • Global Reproductive Genetics Market, By Sample Type
  • Global Reproductive Genetics Market, By End User
  • Global Reproductive Genetics Market, By Methodology
  • Global Reproductive Genetics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Reproductive Genetics Market, By Technology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Preimplantation Genetic Testing (PGT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • PGT-A (Aneuploidy)
    • PGT-M (Monogenic Disorders)
    • PGT-SR (Structural Rearrangements)
• Carrier Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Targeted Mutation Panels
    • Expanded Carrier Screening
• Prenatal Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Non-Invasive Prenatal Testing (NIPT)
    • Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
• Newborn Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Whole Exome Sequencing
    • Targeted Gene Panels

5. Global Reproductive Genetics Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Infertility and IVF Programs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Genetic Disease Risk Assessment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Chromosomal Abnormality Detection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Fetal Health Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Inherited Disorder Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Recurrent Pregnancy Loss Investigation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Reproductive Genetics Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Instruments and Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Sequencers
    • PCR Systems
    • Microarray Platforms
• Consumables and Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • DNA Extraction Kits
    • Amplification Reagents
    • Hybridization Probes
• Software and Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Genetic Data Analysis Tools
    • Counseling and Interpretation Services

7. Global Reproductive Genetics Market, By Sample Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Embryo
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Amniotic Fluid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Maternal Blood
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Buccal Swab
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cord Blood
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Reproductive Genetics Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Fertility Clinics and IVF Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hospitals and Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Research and Academic Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Genetic Counseling Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Reproductive Genetics Market, By Methodology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Next-Generation Sequencing (NGS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Polymerase Chain Reaction (PCR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Fluorescence In Situ Hybridization (FISH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Comparative Genomic Hybridization (CGH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Microarray Analysis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Reproductive Genetics Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Revvity (PerkinElmer)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pacific Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Oxford Nanopore Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• MGI Tech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperSurgical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hamilton Thorne
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vitrolife
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us